TYPHIM Vi is indicated for active immunisation against typhoid fever caused by Salmonella enterica serovar Typhi, S.Typhi.
TYPHIM Vi Prescribing information
Typhoid fever is a bacterial infection that remains common in countries with poor sanitation and hygiene practices. Transmission usually occurs via the faecal-oral route from ingestion of contaminated food or water. Each year, globally, an estimated 11 to 20 million cases of typhoid occur and up to 161,000 deaths.1
TYPHIM Vi provides up to 3 years’ protection against typhoid fever (from day 21 after vaccination). Immunity appears within 1-3 weeks after injection.
|
|
Presentation |
Schedule |
Further doses |
Age range |
|
|
0.5 ml prefilled syringe |
1 dose |
1 dose every 3 years for those at continued risk |
2 years + |
References:
Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.
Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.
• Simply visit https://sanofi.medisa.com
• Select the user group which best describes your role in your organisation
• Narrow your search by selecting the appropriate disease area
• Select which materials you would like to receive and how many
• Log-in or register to create an account
• Confirm your order
MAT-GB-2003242(v1.0) | October 2020
